Announcements Trials

Browse Landscape

Phase

Status

Completed 21 Unknown 4 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 10 Esophageal Neoplasms 4 Neoplasms 3 Urinary Bladder Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Oesophago-gastric Cancer 1 KRAS and NRAS Wild-type Colorectal Cancer 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Cone Dystrophy 3 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Breast Neoplasms 1 Advanced Colorectal Cancer 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

Capecitabine 35 Oxaliplatin 32 Fluorouracil 29 Leucovorin 26 Irinotecan 22 Bevacizumab 19 Cetuximab 17 Radiotherapy 16 Radiation 11 Surgical Procedures, Operative 6 Radiotherapy, Intensity-Modulated 5 Gene Expression Profiling 5 Chemotherapy, Adjuvant 5 Celecoxib 5 Neoadjuvant Therapy 4 Immunohistochemistry 4 Biopsy 4 Amplified Fragment Length Polymorphism Analysis 4 cediranib 3 Reverse Transcriptase Polymerase Chain Reaction 3 Receptor Protein-Tyrosine Kinases 3 Folfox protocol 3 Drug Therapy 3 Cisplatin 3 sargramostim 2 regorafenib 2 pembrolizumab 2 fludarabine phosphate 2 aldesleukin 2 Surveys and Questionnaires 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Rectal Neoplasms × Panitumumab × Clear all

NCT00973193 2016-04-20

PrePaRad

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 2 Terminated

Gastrointestinal

Adenocarcinoma, Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡